Impact of experimental blockade of peripheral growth hormone (GH) receptors on the kinetics of endogenous and exogenous GH removal in healthy women and men.
The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Abstract
Organs that respond to and metabolize GH are enriched in cognate high-affinity receptors. However, whether isologous receptors mediate the de facto access of ligand to cellular degradative pathways is not known. To address this query, we assessed the distribution and whole-body elimination kinetics of (endogenous and exogenous) GH before and after administration of a novel, potent, and selective recombinant human (rh) GH receptor antagonist peptide, pegvisomant. Sixteen healthy young adults (nine men and seven women) participated in a double-blind, prospectively randomized, within-subject cross-over study. The intervention comprised a single sc injection of placebo vs. a high dose of pegvisomant (1 mg/kg sc) timed 62 and 74 h before the overnight sampling and daytime infusion sessions, respectively. The half-life, metabolic clearance rate (MCR), and distribution volume of GH were quantitated by way of: 1) deconvolution analysis of serum GH concentration time series collected every 10 min for 10 h; 2) exponential regression analysis of the decay of GH concentrations after a 6-min iv pulse of rhGH (1 and 10 μg/kg); 3) calculation of the MCR during constant iv infusion of rhGH (0.5 and 5.0 μg/kg every 2 h); and 4) exponential fitting of the elimination time-course of GH concentrations following cessation of each constant infusion. Concentrations of GH and pegvisomant were measured in separate, noncross-reactive, two-site monoclonal, immunofluorometric assays. Pegvisomant concentrations averaged 4860 ± 480 μg/liter (±sem) across the infusion interval, thus exceeding low steady state GH concentrations by 3000-fold. Inhibitory efficacy of the GH receptor antagonist peptide was affirmed by way of a 34% reduction in the serum total IGF-I concentration, i.e., from 257 ± 37 (placebo) to 170 ± 24 (drug) μg/liter (P < 0.001); and a reciprocal 77% elevation of the (10-h) mean GH concentration, i.e., from 1.3 ± 0.23 (placebo) to 2.3 ± 0.42 (drug) μg/liter (P = 0.003). ANOVA disclosed that prior administration of pegvisomant (compared with placebo) did not alter: 1) the calculated half-life (minutes) of secreted GH, which averaged 15 ± 1.3 (placebo) and 14 ± 0.69 (drug); 2) the half-time of disappearance (minutes) of an iv pulse of rhGH, 15 ± 1.0 (placebo) and 13 ± 0.5 (drug) (for the 10 μg/kg dose); 3) the distribution volume (milliliters per kilogram) of rhGH, 59 ± 6.2 (placebo) and 58 ± 3.5 (drug); 4) the steady state GH concentration (micrograms per liter) attained during constant iv infusion of rhGH (at a rate of 5 μg/kg every 2 h), 18.2 ± 2.4 (placebo) and 18.3 ± 2.3 (drug); 5) the half-life (minutes) of elimination of GH from equilibrium, 16 ± 0.98 (placebo) and 16 ± 1.8 (drug); and 6) the steady state MCR (liters per kilogram per day) of rhGH, 3.8 ± 0.32 (placebo) and 3.5 ± 0.31 (drug). In ensemble, the present data refute the a priori postulate that vascular-accessible GH receptors determine the in vivo pseudoequilibrium kinetics of GH disappearance in the human.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“infusion of IGF-I suppresses and experimental reduction of IGF-I concentrations stimulates pulsatile GH secretion by approximately 2-fold (26,27).”
From Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp (2005) · cites this paper as [26]
Citations
Cites
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,239
Growth hormone receptor and serum binding protein: purification, cloning and expression
Leung, D. W., Spencer, S. A., Cachianes, G., Hammonds, R. G., Collins, C., Henzel, W. J., Barnard, R., Waters, M. J., & Wood, W. I. (1987) · Nature · doi:10.1038/330537a0 · Cited by 1,522
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Self-citationTreatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Trainer, P. J., Drake, W. M., Katznelson, L., Freda, P. U., Herman-Bonert, V., van der Lely, A. J., Dimaraki, E. V., Stewart, P. M., Friend, K. E., Vance, M. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421604 · Cited by 879
Self-citationCunningham, B. C., Ultsch, M., de Vos, A. M., Mulkerrin, M. G., Clauser, K. R., & Wells, J. A. (1991) · Science · doi:10.1126/science.1948064 · Cited by 874
Zhou, Y., Xu, B. C., Maheshwari, H. G., He, L., Reed, M., Lozykowski, M., Okada, S., Cataldo, L., Coschigamo, K., Wagner, T. E., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13215 · Cited by 802
Rational Design of Potent Antagonists to the Human Growth Hormone Receptor
Fuh, G., Cunningham, B. C., Fukunaga, R., Nagata, S., Goeddel, D. V., & Wells, J. A. (1992) · Science · doi:10.1126/science.256.5064.1677 · Cited by 631
Veldhuis, J. D., Carlson, M. L., & Johnson, M. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7686 · Cited by 549
Self-citationGrowth Hormone Heterogeneity: Genes, Isohormones, Variants, and Binding Proteins
BAUMANN, G. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-4-424 · Cited by 443
Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization
Smith, L. E. H., Kopchick, J. J., Chen, W., Knapp, J., Kinose, F., Daley, D., Foley, E., Smith, R. G., & Schaeffer, J. M. (1997) · Science · doi:10.1126/science.276.5319.1706 · Cited by 393
Molecular Mechanism of Growth Hormone Action
Carter-Su, C., Schwartz, J., & Smit, L. J. (1996) · Annual Review of Physiology · doi:10.1146/annurev.ph.58.030196.001155 · Cited by 311
Insulin transport across capillaries is rate limiting for insulin action in dogs.
Yang, Y. J., Hope, I. D., Ader, M., & Bergman, R. N. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114339 · Cited by 303
[26] Deconvolution analysis of hormone data
.Veldhuis, J. D., & Johnson, M. L. (1992) · Methods in Enzymology · doi:10.1016/0076-6879(92)10028-c · Cited by 263
Self-citationRoss, R. J. M. (1997) · Molecular Endocrinology · doi:10.1210/me.11.3.265 · Cited by 222
Rational design of receptor-specific variants of human growth hormone.
Cunningham, B. C., & Wells, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3407 · Cited by 208
Schwartz, M. W., Bergman, R. N., Kahn, S. E., Taborsky, G. J., Fisher, L. D., Sipols, A. J., Woods, S. C., Steil, G. M., & Porte, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115431 · Cited by 183
Renal extraction, filtration, absorption, and catabolism of growth hormone
Johnson, V., & Maack, T. (1977) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1977.233.3.f185 · Cited by 166
Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.
Haffner, D., Schaefer, F., Girard, J., Ritz, E., & Mehls, O. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117069 · Cited by 154
Ross, R. J. M., Leung, K. C., Maamra, M., Bennett, W. F., Doyle, N. S., Waters, M. J., & Ho, K. K. Y. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7403 · Cited by 154
Metabolic clearance of biologically active luteinizing hormone in man.
Veldhuis, J. D., Fraioli, F., Rogol, A. D., & Dufau, M. L. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112411 · Cited by 131
Self-citationWirén, L., Bengtsson, B., & Johannsson, G. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00462.x · Cited by 131
Growth Hormone (GH) and a GH Antagonist Promote GH Receptor Dimerization and Internalization
Harding, P. A., Wang, X., Okada, S., Chen, W. Y., Wan, W., & Kopchick, J. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6708 · Cited by 97
Ghinea, N., Mai, T. V., Groyer-Picard, M. T., & Milgrom, E. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.1.87 · Cited by 88
Veldhuis, J. D., Johnson, M. L., Faunt, L. M., Mercado, M., & Baumann, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116243 · Cited by 87
Schaefer, F. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.22 · Cited by 73
Trainer, P. J., Drake, W. M., Perry, L. A., Taylor, N. F., Besser, G. M., & Monson, J. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7664 · Cited by 72
Cameron, D. P., Burger, H., Catt, K. J., Gordon, E., & Watts, J. M. (1972) · Metabolism · doi:10.1016/0026-0495(72)90024-8 · Cited by 70
Cuneo, R. C., Hickman, P. E., Wallace, J. D., Teh, B. T., Ward, G., Veldhuis, J. D., & Waters, M. J. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02031.x · Cited by 69
Self-citationVeldhuis, J. D., Bidlingmaier, M., Anderson, S. M., Wu, Z., & Strasburger, C. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7656 · Cited by 68
Self-citationGrowth Hormone Receptor Antagonism Prevents Early Renal in Nonobese Diabetic Mice
Segev, Y., Landau, D., Rasch, R., Flyvbjerg, A., & Phillip, M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10112374 · Cited by 68
Okada, S., Chen, W. Y., Wiehl, P. E., Kelder, B., GOODMAN, H. M., Guller, S. M., Sonenberg, M., & Kopchick, J. J. (1992) · Endocrinology · doi:10.1210/endo.130.4.1547740 · Cited by 62
Muller, A. F., Janssen, J. A., Hofland, L. J., Lamberts, S. W., Bidlingmaier, M., Strasburger, C. J., & van der Lely, A. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7173 · Cited by 56
Self-citationAmino acid residues in the third alpha-helix of growth hormone involved in growth promoting activity
Chen, W. Y., Chen, N. Y., Yun, J., Wight, D. C., Wang, X. Z., Wagner, T. E., & Kopchick, J. J. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.3.7539887 · Cited by 52
Shah, N., Aloi, J., Evans, W. S., & Veldhuis, J. D. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5881 · Cited by 44
Self-citationReceptor-mediated endocytosis and degradation of bovine growth hormone in rat liver
Husman, B., Gustafsson, J.-Α., & Andersson, G. N. (1988) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(88)90191-8 · Cited by 31
Shah, N. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2862 · Cited by 29
Straume, M., Veldhuis, J. D., & Johnson, M. L. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(94)40046-6 · Cited by 28
Self-citationTurner, T. T., & Rhoades, C. P. (1995) · Journal of Andrology · doi:10.1002/j.1939-4640.1995.tb00556.x · Cited by 21
Veldhuis, P. P., Faunt, L. M., & Johnson, M. L. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(94)40055-5 · Cited by 17
Hansen, T. K., Jørgensen, J. O. L., & Christiansen, J. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8473 · Cited by 16
In-vivo uptake of human growth hormone in male rat liver
Bullier-Picard, F., Postel-Vinay, M. C., & Kayser, C. (1989) · Journal of Endocrinology · doi:10.1677/joe.0.1210019 · Cited by 16
Catalina, P. F., Andrade, M. A., García-Mayor, R. V., & Mallo, F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8438 · Cited by 13
Disappearance of Human Growth Hormone125I in the Anephric Non-Uraemic and Uraemic Rat
Rabkin, R., Pimstone, B. L., Marks, T., & Eales, L. (1972) · Hormone and Metabolic Research · doi:10.1055/s-0028-1094007 · Cited by 13
Research works printed but not linked: 1
- Guyton, 2000, The body fluid compartments: extracellular and intracellular fluids; interstitial fluid and edema, In: Textbook of medical physiology, vol 10. Philadelphia: WB Saunders Co.;, 264
Cited by
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., & Bowers, C. Y. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0038 · Cited by 452
Self-citationSomatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., & Bowers, C. Y. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0006 · Cited by 236
Self-citationHigh-Sensitivity Chemiluminescence Immunoassays for Detection of Growth Hormone Doping in Sports
Bidlingmaier, M., Suhr, J., Ernst, A. S., Wu, Z., Keller, A., Strasburger, C. J., & Bergmann, A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112458 · Cited by 155
Self-citationKopchick, J. J., List, E. O., Kelder, B., Sustarsic, E. G., & Berryman, D. E. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.004 · Cited by 100
Growth Hormone Receptor Antagonists
Muller, A. F., Kopchick, J. J., Flyvbjerg, A., & van der Lely, A. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022049 · Cited by 90
Metadata
- Authors
- Veldhuis, J. D., Bidlingmaier, M., Anderson, S. M., Evans, W. S., Wu, Z., & Strasburger, C. J.
- Affiliations
- University of Virginia Health System (US)
- LMU Klinikum (DE)
- Corresponding author
- Veldhuis, J. D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-12-01
- Volume
- 87
- Issue
- 12
- Pages
- 5737-5745
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2066506983
- Semantic Scholar
- 9bf65d066381e742648f04d341c370c70ba90520
- Cited by
- 61
- References
- 45
- Citations by year
- 2020: 3 · 2017: 4 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Virginia
- Deutsches Krebsforschungszentrum
- National Institutes of Health (RR-00847)
- National Institute on Aging (R01-AG14799-05, AG-19695-01, R01AG014799)
- National Center for Research Resources (M01RR000847, MO1-RR00847)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- growth hormone, growth hormone receptor, pegvisomant, growth hormone receptor antagonist, metabolic clearance rate, volume of distribution, elimination half-life, insulin-like growth factor I, recombinant human growth hormone, healthy adults, sex differences, deconvolution, growth hormone binding protein
- MeSH terms
- Adult, Double-Blind Method, Female, Humans, Kinetics, Male, Prospective Studies, Receptors, Somatotropin, Recombinant Proteins, Reference Values, Cross-Over Studies, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.